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Abstract
Background: Many women in Iran have a relatively high body mass index. To investigate whether
the condition contributes to excess breast cancer cases, a case-control study was conducted to
assess the relationships between anthropometric variables and breast cancer risk in Tehran, Iran.
Methods: All incident cases of breast cancer in the Iranian Centre for Breast Cancer (ICBC) were
identified through the case records. Eligible cases were all postmenopausal women with histological
confirmed diagnosis of breast cancer during 1996 to year 2000. Controls were randomly selected
postmenopausal women attending the ICBC for clinical breast examination during the same period.
The body mass index (BMI) was calculated based on weights and heights as measured by the ICBC
nursing staff. Both tests for trend and logistic regression analysis were performed to calculate odds
ratios and 95% confidence intervals as measures of relative risk.
Results: In all, 116 breast cancer cases and 116 controls were studied. There were no significant
differences between cases and control with regard to most independent variables studied.
However, a significant difference was observed between cases and controls indicating that the
mean BMI was higher in cases as compared to controls (P = 0.004). Performing logistic regression
analysis while controlling for age, age at menopause, family history of breast cancer and parity, the
results showed that women with a BMI in the obese range had a three fold increased risk of breast
cancer [odds ratio (OR) = 3.21, 95% confidence interval (CI): 1.15–8.47].
Conclusion: The results suggest that obesity in postmenopausal women could increase risk of
breast cancer and it merits further investigation in populations such as Iran where it seems that
many women are short in height, and have a relatively high body mass index.
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Background
Although anthropometric characteristics have been evalu-
ated as possible determinants of breast cancer risk [1-3],
studies on the association of obesity with breast cancer
risk in Western women have provided contradictory
results. While postmenopausal women show a positive
association between increased body mass and breast can-
cer risk, the association is found to be negative in pre-
menopausal breast cancer [4,5]. In the New York Univer-
sity Women's Health Study the authors concluded that
excessive body weight increases breast cancer risk in post-
menopausal women. On the contrary, in pre-menopausal
women, excessive body weight may be protective among
women who have a lower-body type of fat accumulation
[6].
Studies suggest that timing of weight gain in an individual
may be more relevant to breast cancer risk than weight
gain at any age [7]. In other words it is argued that being
overweight before the age of 18 years is associated with a
reduced risk of breast cancer in pre-menopausal women,
while being overweight after the age of 18 years is associ-
ated with a higher risk of postmenopausal but not of pre-
menopausal breast cancer [8,9]. Similar observations were
reported in several case-control studies [10,11]. A popula-
tion-based case-control study in Sweden indicated that
women who had gained 30 Kg or more since age 18 had a
twofold risk of breast cancer compared with those who
had maintained their weight unchanged [11]. Overall, the
evidence suggests that postmenopausal women who are
overweight or obese have an increased relative risk of
breast cancer, for instance ranging from 1.23 (CI: 1.00–
1.59) [12] to 2.52 (95% CI: 1.62–3.93) [13].
However, not enough is known about the relationship
between anthropometric variables and risk of breast can-
cer in Asian populations. An international study reported
that in Asian populations with low breast cancer risk, both
pre- and post-menopausal obesity was associated with a
higher risk of breast cancer [14]. Similarly a recent study
from India indicated that increased body mass index,
waist size and hip size were risk factors for breast cancer
both in pre- and postmenopausal women [15]. However,
a study of pre-menopausal Vietnamese and Chinese
women found that body mass index was not significantly
related to breast cancer risk [16].
Only one study has reported on associations between
body mass index and breast cancer risk in Iran [17]. Stud-
ies concerning obesity in Iran indicate that excess body
weight is common among women, and more Iranian
women than men present with overweight and abdomi-
nal obesity [18]. In addition, evidence from Iran suggests
that lack of physical activity and sedentary lifestyle are
responsible for the emerging obesity [19], although the
role of nutrition should not be neglected.
This paper aims to examine the relationship between
anthropometric variables and risk of breast cancer in post-
menopausal women in Tehran, Iran where it seems that
many women have a relatively high body mass index.
Methods
A retrospective case-control study was conducted to assess
the relationships between anthropometric variables and
breast cancer risk in Tehran, Iran. All incident cases of
breast cancer in the Iranian Centre for Breast Cancer
(ICBC) were identified through the case records. Eligible
cases were all postmenopausal women with histologically
confirmed diagnosis of breast cancer (both in situ and
invasive disease) during 1996 to year 2000 and women
with a previous breast cancer diagnosis were excluded.
Controls were randomly selected from postmenopausal
women attending the ICBC for clinical breast examina-
tion during the same period. Menopausal status was
defined when there have been no menses for a year (nat-
ural menopause). Women with bilateral oophorectomy,
hysterectomy, or who reported use of postmenopausal
hormones were excluded from the study. Data on demo-
graphic, medical history and reproductive characteristics
of breast cancer cases and controls were extracted from
case records. The variables of interest were age, marital sta-
tus, educational status, family history of breast cancer, age
at menarche, parity, age at first live birth, number of live
births, age at menopause, previous use of oral contracep-
tives, weight and height at diagnosis. The body mass index
was calculated based on heights and weights as measured
by the ICBC nursing staff [BMI = weight (kg)/height
(m)2]. To avoid measurement error one of the authors car-
ried out duplicate measurements at the same time and the
two measurements were identical as noted by one of us.
Based on the BMI, women were grouped into different cat-
egories as recommended by the WHO: normal range (BMI
= 18.5–24.9 kg/m2), overweight (BMI = 25–29.9 kg/m2),
and obese (BMI ≥ 30 kg/m2) [20].
The sample size was based on an assumption that at least
25% of breast cancer cases and 10% of women in the con-
trol group would be obese. As such, a study with a sample
of 224 women (112 in each group) would have a power
of 80% to estimate an odds ratio of 3 at 95 percent confi-
dence level [21]. The actual sample studied here was 232
postmenopausal women (116 per each group).
Tests for trend were performed to calculate odds ratio and
95% confidence intervals as measures of relative risk. The
test calculates Chi-square for trend, the associated P value
and the odds ratio for each category compared with the
reference category [21]. T-test was carried out to compareBMC Cancer 2008, 8:278 http://www.biomedcentral.com/1471-2407/8/278
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the BMI, height, and weight mean differences between
cases and controls. In addition, logistic regression analysis
was performed to estimate odds ratios for developing
breast cancer while adjusting for age, age at menopause,
family history of breast cancer and parity.
The ICBC board approved the study and all patients were
asked for consent to use their information for the study. In
fact, since there was no interventions involved a member
of the ICBC called each patient (116 cases and 116 con-
trols) to ask for permission to use their information to be
reviewed. All patients gave oral consent.
Results
In all, 116 breast cancer cases and 116 controls were stud-
ied. The characteristics of cases and controls are shown in
Table 1. The mean age for cases was 54.6 (SD = 6.8) while
it was 52.7 (SD = 6.8) for controls (P = 0.03). With regard
to the BMI categories there was a significant difference
between cases and controls (Table 2). In addition, when
the BMI mean difference between cases and controls was
assessed, a significant difference was observed indicating
that the mean BMI was higher in cases as compared to
controls (P = 0.004). Further analysis of data indicated
that breast cancer cases were significantly shorter than
controls (P = 0.00003). With regard to the recent weight,
although the breast cancer cases tended to be heavier,
there was no significant difference between cases and con-
trols (Table 2).
The results obtained from multiple logistic regression
analysis are shown in Table 3 indicating that overweight
and obese women were at higher risk of developing breast
cancer (OR = 2.53, and 3.21 respectively). The analysis
showed that height significantly contributed to the
observed differences.
Discussion
Overweight and obesity are common health conditions
and their prevalence is increasing globally. The World
Health Organization recently called for the continuous
monitoring of BMI to assess the trends in obesity in pop-
ulations across time [22]. It is well known that excess
weight is associated with increased incidence of particular
diseases and certain cancers and those associations of
excess weight with overweight and obesity-related mor-
bidity may differ among racial and ethnic groups [23].
Although the result of this study with a small sample size
could not be generalized, the findings indicated that obes-
ity was a risk factor for developing breast cancer in post-
menopausal women in Iran. The obese women showed
about threefold risk of breast cancer (OR = 3.21) com-
pared to women with a normal body mass index. It is
argued that it is unclear whether this relationship reflects
a causal role of obesity during childhood and adoles-
cence, of weight gain during adult life, or of adult obesity
per se [11]. Recent studies suggest that relation between
breast cancer risk in young women and body weight at dif-
ferent ages is complex and that the risk reduction with
adult weight gain is confined to less aggressive cancers
[24]. In addition, as indicated by some researchers the
critical pathways for understanding the relation between
obesity and breast cancer risk are likely to be depend on
two points in time: at menarche and menopause; time
when some metabolic factors occur and women would
experience some physiological (hormonal) changes in
their body [25,26].
Weight gain and obesity not only are risk factors for breast
cancer, but also contribute to the diagnosis process. A
study from Geneva Cancer Registry, Switzerland com-
pared diagnostic characteristics of obese with non-obese
breast cancer patients. The findings showed that obese
patients presented significantly more often with advanced
stage disease, experienced more surgical delay and pro-
longed hospital stay after surgery. The authors speculated
that the more advanced stage at diagnosis could be due to
the larger breast size of obese women, with more fatty tis-
sue, which can lead to difficulties in palpating the primary
tumor and the axillary lymph nodes. Also, obese women
may be more reluctant to undergo physical examination
because of embarrassment about their weight. They sug-
gest there is a need to educate women and doctors that
self-examination and clinical examination may be less
reliable in obese women, and to think of strategies to pre-
vent advanced disease at diagnosis for this growing group
of patients [27].
There are two measures which are significant to body mass
index and its relation to breast cancer risk: weight and
height. The strength of this study relates to the fact that all
heights and weights were measured by the ICBC nursing
staff rather than relying on self-reported weights and
heights by the cases and controls. Anthropometric studies
usually rely on self-reported measures and the evidence
suggests that obese women tend to underestimate their
weight gain as compared to lean adolescents [28]. In con-
trast, this study was limited due to the fact that weight was
measured at diagnosis. Weight at diagnosis may not
reflect usual weight before disease onset since cases may
have recently lost weight as a result of their breast cancer,
or gained weight due to immobility from feeling badly.
It is argued that adult weight gain is a more important risk
factor for breast cancer than BMI because body mass
gained after young age is mainly adipose tissue (that
increases the risk of breast cancer), while BMI is deter-
mined by fat tissue and lean body mass in combination
(that might not be responsible for increased risk of breast
cancer). Therefore, weight gain might be a better measureBMC Cancer 2008, 8:278 http://www.biomedcentral.com/1471-2407/8/278
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Table 1: Demographic, medical history, and reproductive characteristics of breast cancer cases and controls
Cases (n = 116)
No. (%)
Controls (n = 116)
No. (%)
Odds ratio (95% CI) χ2for trend (P)
Age (years)
< 50 28 (24) 43 (37) 0.6 (0.3–1.4)
50–54 43 (37) 33 (28) 1.3 (0.6–2.0)
55–59 25 (22) 24 (21) 1 (ref.)
60 ≥ 20 (17) 16 (14) 1.2 (0.5–2.9)
1.0 (0.3)
Mean (SD) 54.6 (6.8) 52.7 (6.8) 0.03*
Marital status
never married 7 (6) 4 (4) 1.0 (ref.)
married 86 (74) 84 (72) 0.7 (0.2–2.5)
widowed/divorced 23 (20) 28 (24) 0.6 (0.1–2.3)
0.7 (0.4)
Educational status
illiterate 22 (19) 29 (25) 1.0 (ref.)
primary education 36 (31) 31 (27) 1.5 (0.7–3.3)
secondary education 38 (33) 42 (36) 1.2 (0.6–2.6)
higher education 20 (17) 14 (12) 1.9 (0.7–4.8)
0.9 (0.4)
Family history of breast cancer
none 88 (76) 94 (81) 1.0 (ref.)
first or second degree 28 (24) 22 (19) 1.4 (0.2–9.7)
0.7 (0.4)
Age at menarche (years)
< 13 28 (24) 18 (16) 1.0 (ref.)
13 36 (32) 33 (28) 0.8 (0.3–1.7)
14 26 (22) 37 (32) 0.5 (0.2–1.1)
14 > 26 (22) 28 (24) 0.6 (0.3–1.4)
2.2 (0.1)
Parity
nulliparous 11 (9) 7 (6) 1.0 (ref.)
multiparous 105 (91) 109 (94) 0.7 (0.2–1.9)
0.7 (0.4)
Age at first live birth (years)
14–19 36 (34) 46 (42) 1.0 (ref.)
20–24 44 (42) 43 (40) 1.3 (0.7–2.4)
25–29 17 (16) 13 (12) 1.7 (0.7–4.0)
30 ≥ 8 (8) 7 (6) 1.7 (0.5–5.2)
1.6 (0.2)
Number of live births
none 11 (9) 7 (6) 1.0 (ref.)
1–2 27 (24) 33 (28) 0.6 (0.2–1.8)
3–4 45 (39) 32 (28) 0.9 (0.3–2.9)
> 4 33 (28) 44 (38) 0.5 (0.2–1.5)
0.8 (0.4)
Age at menopause (years)
< 45 29 (25) 40 (35) 1.0 (ref.)
45–50 59 (51) 53 (45) 1.6 (0.8–3.0)
> 50 28 (24) 23 (20) 1.7 (0.8–3.7)
1.9 (0.2)
Previous use of oral contraceptives
none 73 (63) 75 (65) 1.0 (ref.)
yes 43 (37) 41 (35) 1.1 (0.6–2.0)
0.1 (0.8)
* Derived from t-test.BMC Cancer 2008, 8:278 http://www.biomedcentral.com/1471-2407/8/278
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of adult obesity than BMI [8,29] or body fat mass and fat
free mass components of BMI are found to be more discri-
minant factors for breast cancer incidence risk than the
commonly used BMI [30,31]. However, it has not been
shown that reducing body weight can lower breast cancer
risk and this need to be studied further [32].
In this study the breast cancer cases were shorter in height
than controls and it seems that the height was the most
significant factor that contributed to increased breast can-
cer risk in obese women (Table 3). The findings of this
study are challenging and were different from most stud-
ies that support a modest association between height and
breast cancer risk [33]. In fact, the association observed
between breast cancer risk and height in this study is in
the opposite direction of what has been previously
observed in other populations. The Netherlands cohort
study on diet and cancer found that women with a higher
height had an increased risk of breast cancer compared
with shorter women in height [34]. Also height was found
to be a strong predictor of breast cancer risk with compa-
rable effects in both pre-menopausal and postmenopau-
sal women [35]. It is argued that several factors including
genetics, nutrition, diet, and hormone levels all influence
height. A study from Italy has reported that no relation-
ship was observed between the risk of breast cancer
among tallest women compared with the shortest [36].
Similarly studying white women and comparing 5,358
newly diagnosed breast cancer cases and 4,555 controls
there was no association between height and risk of breast
cancer [37].
Finally, this study, as many investigations, showed ele-
vated odds ratios for breast cancer associated with a
number of known risk factors such as family history of
breast cancer, younger ages at menarche, and older ages at
first birth (Table 1). However, since the sample sizes were
small, statistical significance was not achieved. Further
investigations on the topic with larger sample sizes are rec-
ommended.
Conclusion
This study provided data on the fact that obesity could
increase breast cancer risk in postmenopausal women in
Iran. It seems that there is need to publicize obesity as an
important risk factor for breast cancer in Iran. Indeed, this
requires encouraging Iranian women to do more exercise
and follow healthy diets.
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Table 2: Body mass index, height and weight in cases and controls
Cases (n = 116)
No. (%)
Controls (n = 116)
No. (%)
Body mass index (kg/m2)
18.5–24.9 23 (20) 40 (35)
25–29.9 51 (44) 47 (40)
≥ 30 42 (36) 29 (25)
Test for trend χ2 = 7.1, P = 0.03
Mean BMI (SD) 27.9 (3.9) 26.3 (4.3)
T-test t = 2.9, P = 0.004
Height* (Cm)
≤ 157 61 (53) 31 (27)
158–160 29 (25) 34 (29)
161–164 19 (16) 23 (20)
≥ 165 7 (6) 28 (24)
Test for trend χ2 = 23.1, P = 0.00003
Mean height (SD) 158.5 (4.1) 161.3 (5.2)
T-test t = 4.5, P < 0.0001
Weight* (Kg)
≤ 62 24 (21) 30 (26)
63–67 25 (22) 28 (24)
68–75 35 (30) 30 (26)
≥ 76 32 (27) 28 (24)
Test for trend χ2 = 1.49, P = 0.68
Mean weight (SD) 69.5 (7.6) 68.0 (7.4)
T-test t = 1.4, P = 0.14
* The grouping for height and weight are based on approximate quartile values of the control population.BMC Cancer 2008, 8:278 http://www.biomedcentral.com/1471-2407/8/278
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